This report contains market size and forecasts of Lung Cancer Therapeutics in Global, including the following market information:

Global Lung Cancer Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

 

The global Lung Cancer Therapeutics market was valued at 23730 million in 2021 and is projected to reach US$ 45650 million by 2028, at a CAGR of 9.8% during the forecast period.

 

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Targeted Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Lung Cancer Therapeutics include AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Roche, Boehringer Ingelheim GmbH, Pfizer, Sanofi S.A., Bristol-Myers Squibb and Novartis and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Lung Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Lung Cancer Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Lung Cancer Therapeutics Market Segment Percentages, by Type, 2021 (%)

 

  • Targeted Therapy
  • Immunotherapy
  • Chemotherapy
  • Radiation Therapy
  • Others

 

Global Lung Cancer Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Lung Cancer Therapeutics Market Segment Percentages, by Application, 2021 (%)

 

  • Non-Small Cell Lung Cancer (NSCLC)
  • Small Cell Lung Cancer (SCLC)

 

Global Lung Cancer Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Lung Cancer Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

 

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

 

Competitor Analysis

The report also provides analysis of leading market participants including:

 

  • Key companies Lung Cancer Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
  • Key companies Lung Cancer Therapeutics revenues share in global market, 2021 (%)

 

Further, the report presents profiles of competitors in the market, key players include:

 

  • AstraZeneca
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Roche
  • Boehringer Ingelheim GmbH
  • Pfizer
  • Sanofi S.A.
  • Bristol-Myers Squibb
  • Novartis
  • Agennix AG


Table of content

1 Introduction to Research & Analysis Reports
1.1 Lung Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Cancer Therapeutics Overall Market Size
2.1 Global Lung Cancer Therapeutics Market Size: 2021 VS 2028
2.2 Global Lung Cancer Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lung Cancer Therapeutics Players in Global Market
3.2 Top Global Lung Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Lung Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Lung Cancer Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Lung Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lung Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Lung Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Lung Cancer Therapeutics Companies
4 Market Sights by Produ


CONTACT US:
276 5th Avenue, New York, NY 10001, United States
International: +1(646)-781-7170 / +91 8087042414


Similar Reports:

Brazil Squamous Non-Small Cell Lung Cancer Therapeutics Market Insights 2022, Global and Chinese Analysis and Forecast to 2027

2022-2027 Global and Regional Non-small Cell Lung Cancer Therapeutics Industry Status and Prospects Professional Market Research Report Standard Version

Squamous Non-Small Cell Lung Cancer Therapeutics Market Insights 2022, Global and Chinese Analysis and Forecast to 2027

Small Cell Lung Cancer Therapeutics Market - Global Outlook and Forecast 2022-2028